Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire

Sickness Behavior Clinical Trial

Official title:

Turkish Validity and Reliability Study of Virtual Reality Sickness Questionnaire

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04483999
• Other study ID #: VRSQ9
• Status: Completed
• Start date: June 30, 2021
• Est. completion date: March 30, 2023

Study information

• Verified date: April 2023
• Source: Hacettepe University
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This study is planned for the cultural adaptation and validity of the "Virtual Reality Sickness Questionnaire".

Description:

Virtual reality (SG) creates a virtual environment that reflects a real environment and offers various experiences to users. Motion sickness can be observed in people after using virtual reality applications or simulation devices in education. There are questionnaires in the literature such as "Simulator Sickness Questionnaire" and "Motion Sickness Questionnaire". However, these questionnaires are specific surveys to evaluate symptoms that develop after vehicle handling or use of simulation devices for pilot training, while they are not ideal questionnaires to evaluate symptoms that may develop after virtual reality applications. Because there are important differences between virtual reality systems and simulation systems in terms of the appearance of motion disturbance symptoms. For this reason, "Virtual Reality Sickness Questionnaire" has been developed that can evaluate these symptoms.

There is no Turkish version of the "Virtual Reality Sickness Questionnaire" in the literature. For this reason, this study is planned for the cultural adaptation and validity of the "Virtual Reality Sickness Questionnaire".

Recruitment information / eligibility

• Status: Completed
• Enrollment: 100
• Est. completion date: March 30, 2023
• Est. primary completion date: January 30, 2023
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years to 30 Years

Eligibility

Inclusion Criteria:

• Not having mental - cognitive problems,

• Being a volunteer

Exclusion Criteria:

• Oculomotor and vestibular disease

• Cardiovascular, neurological and gastrointestinal problems

Related Conditions & MeSH terms

• Illness Behavior
• Sickness Behavior

Locations

Country	Name	City	State
Turkey	Hatice Çetin	Ankara	Sihhiye

Sponsors (1)

Lead Sponsor	Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Kim HK, Park J, Choi Y, Choe M. Virtual reality sickness questionnaire (VRSQ): Motion sickness measurement index in a virtual reality environment. Appl Ergon. 2018 May;69:66-73. doi: 10.1016/j.apergo.2017.12.016. Epub 2018 Jan 16. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Virtual Reality Sickness Questionnaire	This questionnaire assess virtual reality sickness. This questionnaire consists of 2 subtitles as oculomotor and disorientation. It contains 9 symptoms in total. Each symptom is scored between 0 and 3 with the Likert type scoring system. Each subtitle adapted to be calculated by dividing the total score to a score system in itself like person receives%. The total score of the questionnaire will be obtained by averaging the total scores of the two subtitles.	Change from Baseline sickness after 1 hour later.
Primary	graybiel scale	This questionnaire assess virtual reality sickness. Total score ranges from 0-50. 0-2 points are interpreted as "light susceptibility to motion sickness", 3-7 points as "moderate susceptibility to motion sickness", 8-15 points as "extreme susceptibility to motion sickness", and values above 16 are "Definitive motion sickness".	Change from Baseline sickness after 1 hour later.
Secondary	international physical activity questionnaire	This questionnaire assess physical activity level. The physical activity levels are classified as (< 600 MET-min/week), which is the physically inactive level (level I); (600-3000 METmin/week), which is the level in medium-level (level II) and (> 3000 MET-min/week), which is the high physical activity level.	All of the participants will assess at baseline with this scale.
Secondary	tampa kinesiophobia scale	This questionnaire assess kinesiophobia. The four-point Likert scoring is used in this scale (1 = I do not agree at all, 4 = I agree completely). The total score is calculated after reversing the items 4, 8, 12 and 16. Scoring ranges between 17 and 68 with the higher scores indicating higher levels of kinesiophobia perception.	All of the participants will assess at baseline with this scale.

External Links

•   URL